Heterogeneous nuclear ribonucleoprotein A1 pseudogene 68 (HNRNPA1P68)

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 68 (HNRNPA1P68) is a pseudogene, not an active gene or protein product[1]. Pseudogenes are genic sequences that are similar to known genes but are typically regarded as nonfunctional due to accumulated mutations that prevent normal protein expression or function[5]. Unlike its functional parental gene, *HNRNPA1*, which encodes an RNA-binding protein involved in RNA processing and various aspects of gene regulation, HNRNPA1P68 does not produce a functional protein and is not currently associated with biological functions, molecular targeting, or disease mechanisms relevant to drug development or therapeutic intervention[1][5]. Essential details: - The HNRNPA1P68 gene is specifically annotated as a pseudogene in humans[1]. - There is no evidence supporting its role as a therapeutic target (such as receptor, enzyme, transporter), nor as a biomarker or therapeutic concern[1][5]. - Most references to therapeutic, regulatory, or pathological roles relate to the parental gene, HNRNPA1, not its pseudogenes[2][6]. - Pseudogenes like HNRNPA1P68 can sometimes be transcribed and may play regulatory roles at the RNA level in rare cases, but there is no such functional evidence for HNRNPA1P68 specifically in curated biomedical resources[1][5]. - Queries directed at its use as a molecular target are likely based on a confusion with the functional gene, HNRNPA1, not the pseudogene[1][5]. In summary, HNRNPA1P68 is not a canonical molecular or therapeutic target and is considered a genetically inactive pseudogene[1][5].